TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10100060

Group type: COMPARATOR
Intervention: Intra-arterial BP (i.a.)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Sphygmomanometric BP (sphygmo)
Number of subjects: 93

Group type: COMPARATOR
Intervention: 24-h ambulatory blood pressure (ABPM)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oscillometric BP (Dinamap)
Number of subjects: 93
Study: 8693954

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 0
Study: 1649539

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thiopental/Isuflurane
Number of subjects: 20
Study: 6619453

Group type: EXPERIMENTAL
Intervention: 0.1N HCl infusion at 4 to 5 A.M.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.1N HCl infusion at midnight
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal saline infusion at midnight
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal saline infusion at 4 to 5 A.M.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.1N HCl infusion at 4 to 5 A.M. in patients with a negative Bernstein test
Number of subjects: 9
Study: 31852816

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 2443

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 2443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2443

Group type: EXPERIMENTAL
Intervention: Erenumab (both dosages)
Number of subjects: 2443
Study: 31091374

Group type: EXPERIMENTAL
Intervention: Alpelisib (300 mg per day) plus Fulvestrant (500 mg every 28 days and once on day 15)
Number of subjects: 572

Group type: COMPARATOR
Intervention: Placebo plus Fulvestrant
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Alpelisib-fulvestrant
Number of subjects: 572

Group type: COMPARATOR
Intervention: Placebo-fulvestrant
Number of subjects: 572
Study: 28437508

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 91
Study: 25737487

Group type: EXPERIMENTAL
Intervention: Self-blood pressure monitoring (home blood pressure monitor and training)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 900
Study: 23438190

Group type: EXPERIMENTAL
Intervention: Minimal Shoes (MS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional Shoes (TS)
Number of subjects: 14
Study: 21784413

Group type: EXPERIMENTAL
Intervention: COMET + treatment-as-usual (TAU)
Number of subjects: 93

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 93
Study: 19161608

Group type: EXPERIMENTAL
Intervention: Web-based interactive self-help programme (StopSite)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online self-help guide
Number of subjects: 0
Study: 16763973

Group type: EXPERIMENTAL
Intervention: Grade IV gliomas
Number of subjects: 67

Group type: COMPARATOR
Intervention: Grade II and III gliomas
Number of subjects: 67
Study: 15313689

Group type: EXPERIMENTAL
Intervention: Individually staged nutrition group (individualized group), 50 patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Total parenteral nutrition group (TPN group), 50 patients
Number of subjects: 100
Study: 11273211

Group type: EXPERIMENTAL
Intervention: Prednisone 0.5 mg/kg daily for 8 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 9294477

Group type: EXPERIMENTAL
Intervention: TAM + MPA (medroxyprogesterone acetate 500 mg/day orally)
Number of subjects: 215

Group type: COMPARATOR
Intervention: MPA (substituted for tamoxifen)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: TAM + MPA
Number of subjects: 215

Group type: COMPARATOR
Intervention: MPA
Number of subjects: 215
Study: 8361795

Group type: EXPERIMENTAL
Intervention: Water-in-oil emollient cream applied twice a day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Untreated (control) group
Number of subjects: 34
Study: 3779498

Group type: EXPERIMENTAL
Intervention: Rapid-sequence induction with thiopentone (5 mg X kg‐1) and succinylcholine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Elective induction with thiopentone (5 mg X kg‐1) and succinylcholine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both rapid-sequence and elective induction
Number of subjects: 14
Study: 31713350

Group type: EXPERIMENTAL
Intervention: Tofacitinib 1 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tofacitinib 30 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tofacitinib 15 mg (single dose) followed by 15 mg twice daily for 5 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tofacitinib (all doses)
Number of subjects: 25
Study: 30095153

Group type: EXPERIMENTAL
Intervention: Diet+Vest (weighted vest use during a 22-week behavioral diet intervention targeting 10% weight loss, 1100-1300 kcals/day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Diet (22-week behavioral diet intervention targeting 10% weight loss, 1100-1300 kcals/day)
Number of subjects: 37
Study: 28253904

Group type: EXPERIMENTAL
Intervention: Mobile telephone-delivered intervention including printed materials, one-on-one discussion, and 6 weeks of personalized text messages.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention).
Number of subjects: 100
Study: 26276658

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 425

Group type: COMPARATOR
Intervention: No-statin treatment (Control)
Number of subjects: 425
Study: 24228540

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (homologue Chinese drugs preparations)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (model Chinese drugs)
Number of subjects: 1200
Study: 21348544

Group type: EXPERIMENTAL
Intervention: Resveratrol-containing gel applied daily for 60 days on the right side of the face
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle hydrogel applied on the left side of the face as control
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Resveratrol-containing gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle hydrogel
Number of subjects: 20
Study: 18301313

Group type: EXPERIMENTAL
Intervention: iomeprol-400 (400 mgI/mL, 726 mOsm/kg, N = 76)
Number of subjects: 148

Group type: COMPARATOR
Intervention: iodixanol-320 (320 mgI/mL, 290 mOsm/kg, N = 72)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Comparison of mean SCr change
Number of subjects: 148
Study: 17159170

Group type: EXPERIMENTAL
Intervention: All-polyethylene tibial implants
Number of subjects: 51

Group type: COMPARATOR
Intervention: Metal-backed tibial implants
Number of subjects: 51
Study: 15071247

Group type: EXPERIMENTAL
Intervention: Dual-site right atrial pacing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single-site high right atrial pacing
Number of subjects: 40
Study: 12954679

Group type: EXPERIMENTAL
Intervention: Structured interdisciplinary assessment of older people presenting to the accident and emergency department with a fall
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 9862851

Group type: EXPERIMENTAL
Intervention: Patients without adverse factors (Stage 0)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Patients with at least one adverse parameter (Stage I)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Overall cohort of patients
Number of subjects: 102

Group type: COMPARATOR
Intervention: Independent predictors for mortality
Number of subjects: 102
Study: 8921919

Group type: EXPERIMENTAL
Intervention: 1987 American College of Rheumatology (ACR) criteria for classification of rheumatoid arthritis
Number of subjects: 298

Group type: COMPARATOR
Intervention: Exclusion of disorders with obvious distinguishing extraarticular features or SF findings of monosodium urate crystals
Number of subjects: 298
Study: 1928635

Group type: EXPERIMENTAL
Intervention: Speed‐emphasis instructions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accuracy‐emphasis instructions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Typical instructions emphasizing speed and accuracy equally
Number of subjects: 0
Study: 6404880

Group type: EXPERIMENTAL
Intervention: Ornidazole 500 mg orally every 12 h for seven days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 800 mg orally every 12 h for seven days
Number of subjects: 60
Study: 30113250

Group type: EXPERIMENTAL
Intervention: Sense© intervention
Number of subjects: 10
Study: 28971601

Group type: EXPERIMENTAL
Intervention: 2-4 cups of yogurt per week
Number of subjects: 965

Group type: EXPERIMENTAL
Intervention: ≥5 cups of yogurt per week
Number of subjects: 965

Group type: COMPARATOR
Intervention: <2 cups of yogurt per week (nonoverweight women)
Number of subjects: 965

Group type: COMPARATOR
Intervention: <2 cups of yogurt per week (overweight women)
Number of subjects: 965
Study: 27742968

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block with 5 ml of 0.75% ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ultrasound-guided intermediate cervical plexus block with 5 ml of 0.9% saline (control group)
Number of subjects: 40
Study: 24656314

Group type: EXPERIMENTAL
Intervention: Cystoscopy-assisted surgery (Group A)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional open surgery (Group B)
Number of subjects: 29
Study: 22162245

Group type: EXPERIMENTAL
Intervention: Virgin olive oil (VOO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Natural antioxidants from olive mill wastewater alperujo (phenols; SOP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sunflower oil (SFO)
Number of subjects: 20
Study: 19855076

Group type: EXPERIMENTAL
Intervention: Segmental muscle vibration (SMV) at 120 Hz for 30 minutes after each physical therapy session
Number of subjects: 44

Group type: COMPARATOR
Intervention: General physical therapy
Number of subjects: 44
Study: 17394730

Group type: EXPERIMENTAL
Intervention: Risk of social isolation
Number of subjects: 2641

Group type: EXPERIMENTAL
Intervention: Demographic details, social network, and risk for social isolation
Number of subjects: 2641
Study: 16290961

Group type: EXPERIMENTAL
Intervention: Captopril plus canrenoate (25 mg/d)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Captopril alone (placebo)
Number of subjects: 510
Study: 12011283

Group type: EXPERIMENTAL
Intervention: Anti-NF-L antibodies in PPMS and SPMS
Number of subjects: 140

Group type: COMPARATOR
Intervention: Anti-NF-L antibodies
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Anti-NF-L, antitubulin, and anti-NF-H levels
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: CSF or serum antibodies
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: CSF oligoclonal bands reactive with NF-L
Number of subjects: 140
Study: 9818584

Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum for 20 minutes after each of three meals a day
Number of subjects: 1402

Group type: COMPARATOR
Intervention: Control group (no gum)
Number of subjects: 1402

Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum for high-risk subjects
Number of subjects: 1402
Study: 7710795

Group type: EXPERIMENTAL
Intervention: Injection of a small amount of contrast medium rapidly via the antecubital vein and measurement of aortic transit time (ATT) by single slice dynamic CT.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injection of contrast medium at a high rate, expecting peak hepatic enhancement to occur at ATT plus 8 seconds after the end of injection.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spiral scanning of the liver using thin collimation and caudo-cranial table movement beginning at ATT after the end of contrast medium injection.
Number of subjects: 0
Study: 2559897

Group type: EXPERIMENTAL
Intervention: Oral iodized oil (2 ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intramuscular iodized oil (2 ml)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control villages (no iodine supplementation)
Number of subjects: 6
Study: 407559

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate (BV, 800 microgram daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium cromoglycate (SCG, 80 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo aerosol (single-blind)
Number of subjects: 20
Study: 29679637

Group type: EXPERIMENTAL
Intervention: Recent stimulant users (n=27)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-reactive stimulant users (n=28)
Number of subjects: 55
Study: 28271623

Group type: EXPERIMENTAL
Intervention: Probiotic capsule (BIO-25), twice daily for 8 weeks
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo, twice daily for 8 weeks
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Probiotic capsule (BIO-25)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 25681139

Group type: EXPERIMENTAL
Intervention: Drug treatment with thiazides, alpha-methyldopa, and propranolol; n = 406
Number of subjects: 785

Group type: COMPARATOR
Intervention: Untreated controls; n = 379
Number of subjects: 785
Study: 23950642

Group type: EXPERIMENTAL
Intervention: Memo® (750 mg lyophilized royal jelly, 120 mg G. biloba, 150 mg P. ginseng)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 20508537

Group type: EXPERIMENTAL
Intervention: NEW COOL - combination of consumption of 14 g of ice slurry per kilogram body mass made from a commercial sports drink while applying iced towels
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: STD COOL - whole‐body immersion in cold (10°C) water for 10 min followed by wearing a cooling jacket
Number of subjects: 11

Group type: COMPARATOR
Intervention: CON - no treatment apart from the ad libitum consumption of cold water (4°C)
Number of subjects: 11
Study: 18446389

Group type: EXPERIMENTAL
Intervention: Scaling, root planning, and chlorhexidine rinses for 3 months with systemic administration of doxycycline (100 mg once a day for 15 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scaling, root planning, and chlorhexidine rinses for 3 months without systemic administration of doxycycline
Number of subjects: 60
Study: 16531178

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg followed by vaginal misoprostol 800 mcg after 6-8 hours
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Mifepristone 200 mg followed by vaginal misoprostol 800 mcg after 24 hours
Number of subjects: 1080
Study: 12951336

Group type: EXPERIMENTAL
Intervention: Systematic reviews discussing resistance
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Systematic reviews collecting data on patient response to resistant isolates
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Systematic reviews collecting data on induction of resistance
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Systematic reviews highly relevant to resistance
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Articles discussing or collecting data on resistance
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Articles providing actual data on resistance
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Articles providing data on efficacy in susceptible and resistant pathogens
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Articles providing data on infection or colonization with resistant strains
Number of subjects: 111
Study: 11561298

Group type: EXPERIMENTAL
Intervention: Electrophoresis of sodium oxybutirate
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Electrophoresis of alpha‐tocopherol
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Electrophoresis of dimexide
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 9423974

Group type: EXPERIMENTAL
Intervention: Nonmachinery based system
Number of subjects: 343

Group type: COMPARATOR
Intervention: Machinery based system
Number of subjects: 343
Study: 8353575

Group type: EXPERIMENTAL
Intervention: Heparinized flush solutions
Number of subjects: 5139

Group type: COMPARATOR
Intervention: Nonheparinized flush solutions
Number of subjects: 5139
Study: 2962603

Group type: EXPERIMENTAL
Intervention: Metrizoate 350 mg I/ml
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iohexol 350 mg I/ml
Number of subjects: 60
Study: 1699631

Group type: EXPERIMENTAL
Intervention: NdYAG laser recanalization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Endoscopic intubation
Number of subjects: 40
Study: 31023190

Group type: EXPERIMENTAL
Intervention: Internet-based educational intervention plus peer support-moderated listserv
Number of subjects: 131

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 131
Study: 27966042

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE) using tris-acryl gelatin microspheres ≥500 μm
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 15
Study: 26350448

Group type: EXPERIMENTAL
Intervention: Fortified school snack
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation and deworming
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Fever and poultry ownership
Number of subjects: 1047
Study: 23303058

Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (200 mg at 2300 hours and 200 mg at 0400 hours)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (200 mg at 2300 hours)
Number of subjects: 2
Study: 21112791

Group type: EXPERIMENTAL
Intervention: Martínez-Gimeno Score System (MGSS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Palpation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of MGSS and clinical palpation
Number of subjects: 40
Study: 19882368

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (MTX)
Number of subjects: 0
Study: 17568248

Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control educational intervention
Number of subjects: 0
Study: 12847946

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 84

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 84
Study: 10553492

Group type: EXPERIMENTAL
Intervention: Relapse prevention treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 8728532

Group type: EXPERIMENTAL
Intervention: Wobble board training for 12 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: No training
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Wobble board training
Number of subjects: 61
Study: 1867367

Group type: EXPERIMENTAL
Intervention: 0.0027 mg/kg fentanyl alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.0027 mg/kg fentanyl and 1 mg flumazenil i.v. over 4 min
Number of subjects: 10
Study: 6138063

Group type: EXPERIMENTAL
Intervention: 10 mg midazolam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 mg midazolam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 30 mg midazolam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Midazolam (10, 20, 30 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Brotizolam (0.25 mg)
Number of subjects: 6
Study: 30380356

Group type: EXPERIMENTAL
Intervention: β-glucan beverage (250 mL/day containing 250 mg of dispersible baker's yeast β‐glucan)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: β-glucan beverage
Number of subjects: 357
Study: 30328699

Group type: EXPERIMENTAL
Intervention: Verum-AC (verum acupoints)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control-AC (sham acupoints)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 105
Study: 29528296

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25348221

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23998560

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 521

Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 521
Study: 21463153

Group type: EXPERIMENTAL
Intervention: Medical therapy plus CABG
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Viable myocardium
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Non-viable myocardium
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Treatment assignment
Number of subjects: 1212
Study: 19674449

Group type: EXPERIMENTAL
Intervention: semi-standardised acupuncture
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: gabapentine (900-3600 mg/d)
Number of subjects: 336

Group type: COMPARATOR
Intervention: sham laser acupuncture
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: gabapentine
Number of subjects: 336
Study: 17111004

Group type: EXPERIMENTAL
Intervention: Ex-LG (exercise before low-GI meal)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ex-HG (exercise before high-GI meal)
Number of subjects: 8

Group type: COMPARATOR
Intervention: LG-Ex (low-GI meal before exercise)
Number of subjects: 8

Group type: COMPARATOR
Intervention: HG-Ex (high-GI meal before exercise)
Number of subjects: 8
Study: 15351418

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee replacement (UKR)
Number of subjects: 30
Study: 11050375

Group type: EXPERIMENTAL
Intervention: Needle acupuncture (verum)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 39
Study: 9190629

Group type: EXPERIMENTAL
Intervention: Steroid therapy (low dose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (36 healthy persons)
Number of subjects: 48
Study: 1403587

Group type: EXPERIMENTAL
Intervention: Chlorhexidine irrigant during ultrasonic scaling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water irrigant during ultrasonic scaling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New model ultrasonic scaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional model ultrasonic scaler
Number of subjects: 0
Study: 2936564

Group type: EXPERIMENTAL
Intervention: Nafarelin acetate 250 micrograms daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nafarelin acetate 125 micrograms daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both doses of nafarelin acetate
Number of subjects: 24